Cepharanthine-Loaded Nanoparticles Coated With Macrophage Membranes for Lung Inflammation Therapy

    January 2021 in “ Drug Delivery ”
    Caihong Lu, Jinpeng Zheng, Yaning Ding … Chunsheng Gao
    Studysummary In this study, researchers developed a biomimetic anti-inflammatory nanosystem (MM-CEP/NLCs) that significantly reduced the severity of acute lung injury in vivo by targeting and accumulating in lung inflammation sites, showcasing its potential for treating inflammation.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Roles of Existing Drugs and Drug Targets for COVID-19 Management Metabolism Open · 2021
    2. Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19 Pharmacological Reports · 2020